Perspective: The promises of a holistic view of proteins-impact on antibody engineering and drug discovery

被引:15
作者
Phua, Ser-Xian [1 ]
Chan, Kwok-Fong [1 ]
Chinh Tran-To Su [1 ]
Poh, Jun-Jie [1 ,2 ]
Gan, Samuel Ken-En [1 ,2 ,3 ]
机构
[1] ASTAR, Bioinformat Inst, Singapore, Singapore
[2] APD SKEG Pte Ltd, Singapore, Singapore
[3] ASTAR, P53 Lab, Singapore, Singapore
关键词
DEPENDENT ENHANCEMENT; MONOCLONAL-ANTIBODY; CONFORMATIONAL-CHANGES; ALLOSTERIC POCKET; INSULIN-RECEPTOR; CONSTANT-REGION; BINDING-SITE; NEUTRALIZATION; IDENTIFICATION; COMMUNICATION;
D O I
10.1042/BSR20181958
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The reductionist approach is prevalent in biomedical science. However, increasing evidence now shows that biological systems cannot be simply considered as the sum of its parts. With experimental, technological, and computational advances, we can now do more than view parts in isolation, thus we propose that an increasing holistic view (where a protein is investigated as much as a whole as possible) is now timely. To further advocate this, we review and discuss several studies and applications involving allostery, where distant protein regions can cross-talk to influence functionality. Therefore, we believe that an increasing big picture approach holds great promise, particularly in the areas of antibody engineering and drug discovery in rational drug design.
引用
收藏
页数:10
相关论文
共 86 条
[1]  
Abdel-Magid Ahmed F, 2015, ACS Med Chem Lett, V6, P104, DOI 10.1021/ml5005365
[2]   Analysis and improvements to Kabat and structurally correct numbering of antibody variable domains [J].
Abhinandan, K. R. ;
Martin, Andrew C. R. .
MOLECULAR IMMUNOLOGY, 2008, 45 (14) :3832-3839
[3]   The limits of reductionism in medicine: Could systems biology offer an alternative? [J].
Ahn, Andrew C. ;
Tewari, Muneesh ;
Poon, Chi-Sang ;
Phillips, Russell S. .
PLOS MEDICINE, 2006, 3 (06) :709-713
[4]   Insights into Biological Complexity from Simple Foundations [J].
Albergante, L. ;
Liu, D. ;
Palmer, S. ;
Newman, T. J. .
BIOPHYSICS OF INFECTION, 2016, 915 :295-305
[5]   Toward Understanding "the Ways" of Allosteric Drugs [J].
Amaro, Rommie E. .
ACS CENTRAL SCIENCE, 2017, 3 (09) :925-926
[6]  
[Anonymous], 2015, Oxidative Phosphorylation
[7]   Thermodynamics of allostery paves a way to allosteric drugs [J].
Berezovsky, Igor N. .
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2013, 1834 (05) :830-835
[8]   A Fully Human, Allosteric Monoclonal Antibody That Activates the Insulin Receptor and Improves Glycemic Control [J].
Bhaskar, Vinay ;
Goldfine, Ira D. ;
Bedinger, Daniel H. ;
Lau, Angela ;
Kuan, Hua F. ;
Gross, Lisa M. ;
Handa, Masahisa ;
Maddux, Betty A. ;
Watson, Susan R. ;
Zhu, Shirley ;
Narasimha, Ajay J. ;
Levy, Raphael ;
Webster, Lynn ;
Wijesuriya, Sujeewa D. ;
Liu, Naichi ;
Wu, Xiaorong ;
Chemla-Vogel, David ;
Catarina Tran ;
Lee, Steve R. ;
Wong, Steve ;
Wilcock, Diane ;
White, Mark L. ;
Corbin, John A. .
DIABETES, 2012, 61 (05) :1263-1271
[9]  
Bieber T., 2015, PERSONALIZED TREATME, V2015, P1
[10]   A conformational switch high-throughput screening assay and allosteric inhibition of the flavivirus NS2B-NS3 protease [J].
Brecher, Matthew ;
Li, Zhong ;
Liu, Binbin ;
Zhang, Jing ;
Koetzner, Cheri A. ;
Alifarag, Adham ;
Jones, Susan A. ;
Lin, Qishan ;
Kramer, Laura D. ;
Li, Hongmin .
PLOS PATHOGENS, 2017, 13 (05)